Ginkgo Bioworks Holdings, Inc. (DNA) Form 10-K Annual Reports
Ginkgo Bioworks Holdings, Inc. (DNA) is a publicly traded company on the NYSE, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DNA
CIK: 1830214
Exchange: NYSE
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerBrian McAllister
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001628280-26-065349 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001959173-26-007259 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001959173-26-007017 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-15 | FORM 4 | 0001628280-26-062239 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001959173-26-006973 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0001628280-26-058939 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001959173-26-006388 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001959173-26-006078 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-054298 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001628280-26-053319 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001628280-26-051089 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001628280-26-051087 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001628280-26-051084 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001628280-26-051041 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-30 | — | SCHEDULE 13G/A Filing | 0002012383-26-003187 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | FORM 4 | 0001628280-26-048832 | View SEC Doc Filr Page |
| 144 | 2026-07-17 | — | 144 Filing | 0001959173-26-005273 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001628280-26-043299 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001628280-26-043296 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001628280-26-043293 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001628280-26-043291 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-11 | 8-K | 0001628280-26-042932 | View SEC Doc Filr Page |
| 144 | 2026-06-10 | — | 144 Filing | 0001959173-26-004504 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-21 | FORM 4 | 0001628280-26-038202 | View SEC Doc Filr Page |
| 144 | 2026-05-22 | — | 144 Filing | 0001959173-26-003936 | View SEC Doc Filr Page |